ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 718728 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 718728; 2) Community: the network communities that were significantly associated with the response to NSC 718728; 3) Molecule: the relationships between components within communities and NSC 718728; 4) MDR: the compounds that were significantly associated with the NSC 718728.

NSC Compound Enrichment Correlation
NSC 756166 GSK312948A 0.0112113991710615 0.45311634
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0112113991710615 0.43973764
NSC 88054 Null 0.0112113991710615 0.36644553
NSC 94600 Camptothecin 0.0112113991710615 -0.033725311
NSC 669727 Null 0.0112425217758227 0.061501254
NSC 683557 Camptothecin Derivative 0.0112425217758227 -0.048148201
NSC 698398 1,3-Butadiene-1,1-diamine, 3,4-dichloro-2,4-dinitro-N,N'-diphenyl-, (3E)- 0.0112425217758227 0.042319139
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0112425217758228 0.35170931
NSC 627745 Null 0.0112425217758228 0.36622267
NSC 632129 (E)-1-(2,5-Dihydroxyphenyl)ethene-2-isonitrile 0.0112425217758228 0.32156444
Total:83  Current:24    [First] [Prev] [Next] [Last]